Serum Calprotectin: A promising Biomarker for Inflammatory Bowel Disease [IBD]

Background: These days, inflammatory bowel disease [IBD] is growing more common. Its diagnosis relies on invasive techniques like colonoscopy and biopsy, and its activity is monitored by fecal calprotectin levels that have a low compliance rate, so there is a pressing need for a serum biomarker that...

Full description

Bibliographic Details

Published in:	International Journal of Medical Arts
Main Authors:	Nehal Azab, Hala Talkhan, Dalia Samaha, hagar Elessawy, Lamyaa Salem
Format:	Article
Language:	English
Published:	Al-Azhar University, Faculty of Medicine (Damietta) 2022-01-01
Subjects:	serum calprotectin biomarker inflammatory bowel disease crohn's disease ulcerative colitis
Online Access:	https://ijma.journals.ekb.eg/article_211793_e4bfeb412d1a63114e65101643929cf8.pdf